Response by Khosrow-Khavar et al to Letters Regarding Article, "Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study"

Circulation. 2020 Sep 15;142(11):e158-e159. doi: 10.1161/CIRCULATIONAHA.120.049327. Epub 2020 Sep 14.

Farzin Khosrow-Khavar^{1

2

3}, Kristian B Filion^{1

2

4}, Nathaniel Bouganim^{3

5}, Samy Suissa^{1

2}, Laurent Azoulay^{1

2

3}

¹ Centre for Clinical Epidemiology, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada (F.K.-K., K.B.F., S.S., L.A.).
² Department of Epidemiology, Biostatistics, and Occupational Health (F.K.-K., K.B.F., S.S., L.A.), McGill University, Montreal, QC, Canada.
³ Gerald Bronfman Department of Oncology (F.K.-K., N.B., L.A.), McGill University, Montreal, QC, Canada.
⁴ Division of Clinical Epidemiology, Department of Medicine (K.B.F.), McGill University, Montreal, QC, Canada.
⁵ Department of Oncology, Cedar Cancer Center, McGill University Health Center, Montreal, QC, Canada (N.B.).

No abstract available

Publication types